GSK and the University of Cambridge have announced a £50 million, five-year collaboration called the Cambridge-GSK ...

Two public companies focused on RNA editing therapies, Korro Bio and ProQR, enjoyed impressive stock surges powered by their best-ever one day gains; their share prices lifted by Wave Life Sciences ...

The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

Europe’s drug regulator recommended two novel vaccines for influenza alongside updated composition for two COVID-19 vaccines ...

This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.

This hypercar boasts a blend of race-inspired aerodynamics and scissor doors. Under the hood, the F80 features a hybrid powertrain, combining a V6 turbo engine with three electric motors. Together, ...

Northwestern University sued vaccine maker Moderna, Inc. on Wednesday, October 16, in the U.S. District Court for the ...

Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...

Flu season is almost here, and there is a respiratory syncytial virus (RSV) vaccine update worth monitoring. Earlier today, ...